Clinical Trials Logo

Filter by:
NCT ID: NCT00184925 Terminated - Pneumonia Clinical Trials

Ventilator Associated Pneumonia and Late Complications of Percutaneous Tracheostomy

Start date: October 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the incidence of ventilator associated pneumonia and late complications by comparing two different cannulas and two different percutaneous tracheostomy techniques.

NCT ID: NCT00184548 Terminated - Trauma Clinical Trials

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

CONTROL
Start date: October 2005
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The purpose of the trial is to evaluate that activated recombinant human factor VII (eptacog alfa (activated)) is safe and effective in severely injured trauma patients by assessing mortality and morbidity. Please note that this trial and trial F7TRAUMA-1648 (NCT00323570) have been merged.

NCT ID: NCT00180830 Terminated - Cancer Clinical Trials

Glivec Phase II Pediatric Study

Start date: December 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Glivec is effective, in children, adolescents and young adults, in the treatment of malignant disease in which evidence suggests a potential pathogenic role of one or more of the tyrosine kinases known to be inhibited by Glivec.

NCT ID: NCT00162786 Terminated - Healthy Clinical Trials

Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance

Start date: May 2005
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to measure and compare the acute effects of rupatadine 10 mg, relative to placebo and hydroxyzine 50 mg as an active control on healthy volunteers’ performance on a standard over-the-road driving test and a car-following test.

NCT ID: NCT00160004 Terminated - Clinical trials for Amyotrophic Lateral Sclerosis

The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis

Start date: March 2006
Phase: Phase 1/Phase 2
Study type: Interventional

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disorder characterized by amongst others asymmetric muscle weakness, respiratory insufficiency and spasticity. The disease is usually fatal within 2-3 years and until now there is no cure. ALS patients are usually supported by a multidisciplinary team. One of the members of this team is the physical therapist. The aim of physical therapy might be to enhance or to preserve cardiovascular fitness and muscle strength. Some authors suggest, however, that a moderate to high intensive exercise programme might lead to overuse weakness (an undesired fast progression of muscle weakness). The primary objective of this study is therefore to investigate whether regular moderate to high intensity exercise program in ALS can maintain or optimize cardiorespiratory fitness and muscle strength. A secondary objective is to investigate whether such a programme leads to overuse weakness and if there is a positive influence on patient's disability, fatigue and quality of life.

NCT ID: NCT00159978 Terminated - Clinical trials for Head and Neck Neoplasms

Validation of 18F-MISO-PET and 18F-FLT-PET

Start date: July 2005
Phase: Phase 1
Study type: Observational

Hypoxia and tumor cell proliferation are important mechanisms contributing to resistance to radiotherapy in human head and neck tumor cells. Currently, assessment of these two tumor characteristics is performed in biopsies using immunohistochemical staining and subsequent analysis. A promising non-invasive method of characterizing a tumor is the use of positron-emission tomography (PET). Specific tracers can be used to detect hypoxia and proliferative activity. 18F-misonidazole is a tracer for hypoxia and 18F-thymidine is a tracer for proliferation. Patients suffering from head and neck cancer and who will undergo surgery will be included in this study. One week before the surgery the patients will undergo a CT-scan and a PET-scan with either of the tracers. Shortly before the surgery they will be given immunohistochemically detectable marker substances enabling the characterization of the tumor samples gathered from the resection specimen. These markers are pimonidazole for detection of hypoxia and iododeoxyuridine for detection of tumor cell proliferation. The data collected by PET-scan will be analysed and compared to the results acquired by immunohistochemistry.

NCT ID: NCT00159640 Terminated - Pain Clinical Trials

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

Start date: February 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of PD-217,014 in the treatment of chronic pain following a shingles infection.

NCT ID: NCT00158847 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Modification Of Disease Outcome In COPD

Start date: April 2000
Phase: Phase 4
Study type: Interventional

The hypothesis to be tested of this study is that treatment with fluticasone propionate leads to an initial improvement in symptoms, quality of life and lungfunction and a reduction in airways hyperresponsiveness. The continued decline of lungfunction in COPD may not be influenced by longer lasting treatment. Addition of salmeterol will augment the initial benefits of fluticasone without changing the longterm decline in lungfunction.

NCT ID: NCT00157248 Terminated - Stroke Clinical Trials

Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048

Start date: December 2003
Phase: Phase 2
Study type: Interventional

To determine the long term safety and efficacy of BIBR 1048 in patients with chronic atrial fibrilla tion, with or without concomitant chronic treatment with acetylsalicylic acid (ASA).

NCT ID: NCT00151788 Terminated - Atherosclerosis Clinical Trials

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.

Start date: February 2004
Phase: Phase 2/Phase 3
Study type: Interventional

The effects of pactimibe versus placebo on the progression of atherosclerosis in the carotid arteries will be assessed using standard ultrasound techniques.